INSIGHTS ON CLINICAL TRIAL PARTNERING

• Do CROs Need To Reinvent Themselves In 2025?

  Facing economic pressures, regulatory changes, and technological advancements, CROs must redefine their value propositions and discuss the need for reinvention in 2025 to accelerate into the future.

• Building Blocks For Strategic Patient Support In Clinical Trials

  Let’s talk about some tangible building blocks necessary to achieve the next evolution of patient support and explore the effects of strategic payment, budgeting, and logistics solutions.

• Ensure The Safe And Efficient Development Of High Potent Drug Products

  As your product transitions from clinical phases to commercial launch, flexible, globally compliant facilities stand ready to adapt to your evolving needs.

• Turning Innovation Into Execution In CNS Trials

  SCOPE 2026 experts called for practical planning, iterative testing, and real‑world workflows in mental health research, highlighting mock visits, expanded roles, engagement, and psychedelic safety.

   

   

   

   

   

• Relieving The Strain Of Publishing During Regulatory Registration

  8/7/2024

  Go inside how an expertly handled NDA submission for a biopharma company ensured timely FDA approval despite challenges.

• Are You Paying Participants Enough? Your Top Questions Answered

  6/24/2025

  Explore key themes surrounding payments to clinical research participants in depth, with a particular focus on the role of participant compensation and best practices in payment logistics.

• Mitigating Risk And Complexity In Cell & Gene Therapy Trials With IRT

  8/19/2025

  CGT pioneers require supply chain partnerships that mitigate trial risk and complexity. Explore how to optimize pre-trial and pre-screening activities and reduce trial cost and risk with an IRT solution.

• How Australia's Top CRO Speeds Biotech to Global Markets

  4/8/2026

  The next era of clinical trials will be defined by global expansion across the Asia-Pacific region, rapid and cost-effective pathways to regulatory approval, and reliable, patient-centric leadership.

• Harnessing AI for Pre-Award Landscape Analysis And Site Selection

  1/16/2026

  AI-driven insights transform site selection and feasibility, enabling faster decisions and reducing risk. Predictive modeling and real-time data improve pre-award planning and trial outcomes.